Here are relevant reports on : automotive-diagnostics-market
-
Microbiome Diagnostics Market by Product (Kits & Reagents, Instruments), Technology (16s rRNA Sequencing, Shot Gun Metagenomics, Metatranscriptomics), Sample (Fecal, Saliva, Skin), Application (GI, Metabolic Disorders) - Global Forecast to 2028
The global microbiome diagnostics market, valued at US$126 million in 2022, stood at US$146 million in 2023 and is projected to advance at a resilient CAGR of 15.5% from 2023 to 2028, culminating in a forecasted valuation of US$300 million by the end of the period. Market growth is driven by the rising incidence of chronic diseases, collaborative efforts between microbiome industry and academic institutes, and growing demand of personalized medicine.
- Published: February 2024
- Price: $ 4950
- TOC Available:
-
Glycomics Market / Glycobiology Market by Product (Enzymes (Glycosidases, Transferases), Instruments (Mass Spectrometry, Chromatography, Arrays), Kits, Carbohydrates, Reagents), Application (Drug Discovery, Diagnostics), End User - Global Forecast to 2027
The global glycomics market in terms of revenue was estimated to be worth $1.8 Billion in 2022 and is poised to reach $3.7 billion by 2027, growing at a CAGR of 15.5% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: November 2022
- Price: $ 4950
- TOC Available:
-
Metabolism Assays Market Size, Share & Trends by Product (Instruments, Assays Kits), Technology (Colorimetry, Fluorimetry, Spectrometry), Application (Diagnostics (Diabetes, Obesity), Research), End User (Hospitals, Diagnostic Laboratories), & Region - Global Forecast to 2028
The global metabolism assays market, valued at US$1.3B in 2022, is forecasted to grow at a 7.8% CAGR, reaching US$1.4B by 2023 and US$2.1B by 2028. The comprehensive research encompasses an exhaustive examination of industry trends, meticulous pricing analysis, patent scrutiny, insights derived from conferences and webinars, identification of key stakeholders, and a nuanced understanding of market purchasing dynamics.
- Published: September 2023
- Price: $ 4950
- TOC Available:
-
Edge Computing in Healthcare Market by Component (Hardware, Software, Services), Application (Diagnostics, Robotic Surgery, Telehealth, RPM, and Ambulances), End User (Hospitals, Clinics, Ambulatory Care Center), & Region - Global Forecast to 2028
The global edge computing in healthcare market, valued at US$4.1 billion in 2022, stood at US$4.9 billion in 2023 and is projected to advance at a resilient CAGR of 26.1% from 2023 to 2028, culminating in a forecasted valuation of US$12.9 billion by the end of the period. Edge computing is gaining popularity across industries as there is a rise in the number of devices, which has increased the demand for high-bandwidth applications with the growing use of internet services.
- Published: May 2023
- Price: $ 4950
- TOC Available:
-
Laser Capture Microdissection Market by Product (Instruments, Consumables, Software, Services), System Type (Ultraviolet, Infrared, Immunofluorescence), Application (R&D (Molecular Biology, Cell Biology, Forensics), Diagnostics) & Region - Global Forecast to 2029
The global laser capture microdissection market, valued at US$176 million in 2023, stood at US$184 million in 2024 and is projected to advance at a resilient CAGR of 10.6% from 2024 to 2029, culminating in a forecasted valuation of US$306 million by the end of the period. The growth of this market is majorly driven by the rising pace of R&D and growing expenditure. On the other hand, requirement of high degree of technical expertise is a major factor restraining market growth to a certain extent.
- Published: March 2024
- Price: $ 4950
- TOC Available:
-
C – Reactive Protein Testing Market by Assay Type (ELISA, Turbidimetric, Immunoturbidimetric), Application (Cardiovascular, Inflammatory Disease, Rheumatoid Arthritis, Cancer), End User (Hospitals, Clinics, Diagnostics Labs) - Global Forecast to 2023
The Global C-Reactive Protein Testing market is expected to reach USD 1.75 billion by 2023 from USD 1.62 billion in 2018, growing at a CAGR of 1.5 % from 2018 to 2023. Growing occurrences of Non Communicable Diseases (NCDs) such as Cardiovascular Diseases, Diabetes and other inflammatory diseases are the major drivers for this market. Point of Care technology for CRP testing is also being used for diagnostic purposes.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Laboratory Proficiency Testing Market by Industry (Clinical Diagnostics, Microbiology, Pharmaceutical, Food & Animal Feed, Water, Opioid), Technology (PCR, Cell Culture), and Region; Unmet Needs, Stakeholder & Buying Criteria - Global Forecast to 2028
The global laboratory proficiency testing market, valued at US$1.1 billion in 2022, stood at US$1.2 billion in 2023 and is projected to advance at a resilient CAGR of 7.4% from 2023 to 2028, culminating in a forecasted valuation of US$1.6 billion by the end of the period. The proficiency testing market is projected to experience substantial expansion in the forecasted period due to its mandatory requirement for laboratories operating in various regulated industries like APIAC, CLIA, and CLSI.
- Published: October 2023
- Price: $ 4950
- TOC Available:
-
Lymphedema Diagnostics Market by Technology (Lymphoscintigraphy, MRI, Near IR Fluorescence Imaging, Ultrasound), Disease Type (Cancer, Inflammatory Diseases, Cardiovascular, Filariasis), End User (Hospitals, Diagnostic Centers) - Global Forecasts to 2024
The Lymphedema Diagnostics Market is expected to grow from USD 24 million in 2019 to USD 35 million by 2024, at a CAGR of 7.4% during the forecast period. The major players operating in the lymphedema diagnostics market are GE Healthcare (US), Philips (Netherlands), and Siemens Healthineers (Germany). Other prominent players in this market include Canon, Inc. (Japan), Shimadzu Corporation (Japan), Stryker Corporation (US), Fluoptics (France), United Imaging Healthcare Co., Ltd. (China), Hitachi, Ltd. (Japan), Esaote, SpA (Italy), Neusoft Corporation (China), Mindray Medical International, Ltd. (China), Mitaka USA, Inc. (US), Curadel, LLC (US), and ImpediMed Ltd. (Australia).
- Published: October 2019
- Price: $ 4950
- TOC Available:
-
DNA Diagnostics Market by Product (Instruments, Reagents & Kits, Services & Software), Technology (PCR, Mass Spectroscopy, Microarrays), Application (Infectious Disease (Hepatitis, HIV, HPV), Oncology), Specimen (Blood, Urine) - Global Forecast to 2029
The global DNA diagnostics market, valued at US$12.3 billion in 2023, stood at US$13.3 billion in 2024 and is projected to advance at a resilient CAGR of 9.7% from 2024 to 2029, culminating in a forecasted valuation of US$21.2 billion by the end of the period. Growth in the market is primarily driven by the technological improvements in the DNA diagnostics industry and the growing need for personalized treatment and early disease diagnosis in developing nations. Also, the increased investments by healthcare-based companies are majorly contributing to growth of the market.
- Published: July 2024
- Price: $ 4950
- TOC Available:
-
Employee Transport Fleet Management Market by Solution (Operations Management, Vehicle Maintenance & Diagnostics, Performance Management, Compliance Management) & Fleet Type (Fixed-route, First- & Last-mile, Campus) - Global Forecast to 2030
The employee fleet management market is projected to reach USD 9.25 billion by 2030 from USD 4.85 billion in 2025, at a CAGR of 13.8% from 2025 to 2030. The key players include Samsara (US), Geotab (Canada), Verizon Connect (US), Teletrac Navman (US), MiX Telematics (South Africa), Motive (US), TransLoc (US), Via (US), Omnitracs (US), Webfleet (Netherlands), Azuga (US), Ridecell (US), Fleetio (US), Zonar Systems (US), and Trimble (US)
- Published: May 2026
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
